Joel Greenblatt acquired 18.3 Thousand Edwards Lifesciences shares worth $1.61 Million. That's 0.03% of their equity portfolio (661st largest holding). The first Edwards Lifesciences trade was made in Q4 2012. Since then Joel Greenblatt bought shares fifteen more times and sold shares on sixteen occasions. The investor's estimated purchase price is $1.7 Million, resulting in a loss of 5.5%.